- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Got Smallpox Vaccine as a Child? You’re Probably Immune to Mpox
Smallpox vaccines, which were routinely given into the 1970s, seem to provide protection from mpox, a new study says.
The mpox virus, responsible for a worldwide outbreak last year, could surge again this summer, public health experts have warned. It was previously called monkeypox.
Researchers at the Karolinska Institute in Sweden wondered whether the smallpox vaccine would offer some level of immunity against mpox due to a residual memory response. Mpox is among orthopoxviruses that have similarities to smallpox, which was eradicated in the mid-1970s.
“The findings from our study demonstrate that this holds true, indicating that the memory cells exhibit remarkable longevity and possess the ability to identify closely related viruses like the mpox virus,” said co-author Marcus Buggert, a researcher at Karolinska’s Center for Infectious Medicine.
“They can offer overlapping immunity or cross-reactive protection,” Buggert added in an institute news release.
The team examined T-cell immune response in 105 healthy blood donors, finding that people born before 1976 had a notably robust immune response against both viral types.
They then evaluated the immune response in 22 men who recently contracted mpox, finding that they also had a vigorous immune response to the virus.
The authors said this suggests the potential for future immunity among those individuals.
The sample size was insufficient for researchers to determine how much protection prior vaccination offered, but a recently published British study sheds light on that, Buggert said.
“According to this study, the smallpox vaccine has demonstrated the potential to offer approximately 80% protection against mpox,” Buggert said.
Mpox is primarily transmitted through close physical contact with an infected individual, such as during sexual activity. In the 2022 outbreak, it was commonly spread among gay and bisexual men.
Symptoms include blistering, sores, rashes, fever and swollen glands.
The study findings were published recently in the journal Cell Host & Microbe.
More information
The World Health Organization has more on mpox.
SOURCE: Karolinska Institute, news release, May 23, 2023
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.